How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
The poverty prevention effects of health insurance: evidence from China's basic medical insurance program. [PDF]
Yuan X, Yang X, Zhou X.
europepmc +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Analysis of the current situation and influencing factors of burnout of medical insurance specialists in public hospitals in Guangxi, China under the background of the "Sanming Model" reform- cases of healthcare system reform from low and middle income regions. [PDF]
Wu Y +9 more
europepmc +1 more source
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Medical insurance integration and spatial effects in China: evidence from quasi-natural experiments and linked administrative data. [PDF]
Yan J.
europepmc +1 more source
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran +5 more
wiley +1 more source
Study on the willingness to enroll in the urban and rural residents basic medical insurance: from the perspectives of policy awareness and institutional trust. [PDF]
Yu Q +8 more
europepmc +1 more source
Abstract Aim Individual second‐generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second‐generation antihistamines is associated with the risk of injury during Japan's pollen season. Methods We conducted a
Jumpei Taniguchi +3 more
wiley +1 more source
Publisher Correction: China's universal medical insurance scheme: progress and perspectives. [PDF]
Zhang J, Zhao D, Zhang X.
europepmc +1 more source

